In patients with known HF, those with concurrent cancer demonstrated significantly (p < 0.01) elevated NT-proBNP levels, with an average of 1597.50 pg/mL compared to 1114.89 pg/mL without cancer. The gene discussed is NPPB; the disease is cancer.